Share-based Payment Arrangement, Expense of IRONWOOD PHARMACEUTICALS INC from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
IRONWOOD PHARMACEUTICALS INC quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • IRONWOOD PHARMACEUTICALS INC Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $3,823,000, a 16% decline year-over-year.
  • IRONWOOD PHARMACEUTICALS INC Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2025 was $17,250,000, a 42% decline year-over-year.
  • IRONWOOD PHARMACEUTICALS INC annual Share-based Payment Arrangement, Expense for 2025 was $17,250,000, a 42% decline from 2024.
  • IRONWOOD PHARMACEUTICALS INC annual Share-based Payment Arrangement, Expense for 2024 was $29,850,000, a 50% decline from 2023.
  • IRONWOOD PHARMACEUTICALS INC annual Share-based Payment Arrangement, Expense for 2023 was $59,553,000, a 120% increase from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

IRONWOOD PHARMACEUTICALS INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $17,250,000 $3,823,000 -$743,000 -16% 01 Oct 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $17,993,000 $3,612,000 -$4,717,000 -57% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $22,710,000 $4,524,000 -$4,046,000 -47% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $26,756,000 $5,291,000 -$3,094,000 -37% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $29,850,000 $4,566,000 -$4,136,000 -48% 01 Oct 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $33,986,000 $8,329,000 +$423,000 +5.4% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025 2025 Q3
Q2 2024 $33,563,000 $8,570,000 -$27,244,000 -76% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025 2025 Q2
Q1 2024 $60,807,000 $8,385,000 +$1,254,000 +18% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q4 2023 $59,553,000 $8,702,000 +$1,411,000 +19% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $58,142,000 $7,906,000 +$839,000 +12% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $57,303,000 $35,814,000 +$29,213,000 +443% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $28,090,000 $7,131,000 +$1,042,000 +17% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $27,048,000 $7,291,000 +$1,201,000 +20% 01 Oct 2022 31 Dec 2022 10-K 31 Mar 2025 2024 FY
Q3 2022 $25,847,000 $7,067,000 +$861,000 +14% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $24,986,000 $6,601,000 +$2,012,000 +44% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 $22,974,000 $6,089,000 +$693,000 +13% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 $22,281,000 $6,090,000 -$3,918,000 -39% 01 Oct 2021 31 Dec 2021 10-K 16 Feb 2024 2023 FY
Q3 2021 $26,199,000 $6,206,000 -$1,506,000 -20% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 $27,705,000 $4,589,000 -$2,502,000 -35% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2022 Q1
Q1 2021 $30,207,000 $5,396,000 -$968,000 -15% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q4 2020 $31,175,000 $10,008,000 +$4,521,000 +82% 01 Oct 2020 31 Dec 2020 10-K 16 Feb 2023 2022 FY
Q3 2020 $26,654,000 $7,712,000 +$2,192,000 +40% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021 2021 Q3
Q2 2020 $24,462,000 $7,091,000 +$754,000 +12% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2
Q1 2020 $23,708,000 $6,364,000 -$7,570,000 -54% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q4 2019 $31,278,000 $5,487,000 -$4,601,000 -46% 01 Oct 2019 31 Dec 2019 10-K 18 Feb 2022 2021 FY
Q3 2019 $35,879,000 $5,520,000 -$6,648,000 -55% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2020 Q3
Q2 2019 $42,527,000 $6,337,000 -$3,446,000 -35% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020 2020 Q2
Q1 2019 $45,973,000 $13,934,000 +$4,891,000 +54% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q4 2018 $41,082,000 $10,088,000 +$4,299,000 +74% 01 Oct 2018 31 Dec 2018 10-K 17 Feb 2021 2020 FY
Q3 2018 $36,783,000 $12,168,000 +$3,471,000 +40% 01 Jul 2018 30 Sep 2018 10-Q 31 Oct 2019 2019 Q3
Q2 2018 $33,312,000 $9,783,000 +$643,000 +7% 01 Apr 2018 30 Jun 2018 10-Q 30 Jul 2019 2019 Q2
Q1 2018 $32,669,000 $9,043,000 +$1,764,000 +24% 01 Jan 2018 31 Mar 2018 10-Q 02 May 2019 2019 Q1
Q4 2017 $30,905,000 $5,789,000 -$1,594,000 -22% 01 Oct 2017 31 Dec 2017 10-K 13 Feb 2020 2019 FY
Q3 2017 $32,499,000 $8,697,000 +$1,764,000 +25% 01 Jul 2017 30 Sep 2017 10-Q 06 Nov 2018 2018 Q3
Q2 2017 $30,735,000 $9,140,000 +$1,043,000 +13% 01 Apr 2017 30 Jun 2017 10-Q 06 Aug 2018 2018 Q2
Q1 2017 $29,692,000 $7,279,000 +$473,000 +7% 01 Jan 2017 31 Mar 2017 10-Q 04 May 2018 2018 Q1
Q4 2016 $29,219,000 $7,383,000 +$883,000 +14% 01 Oct 2016 31 Dec 2016 10-K 25 Feb 2019 2018 FY
Q3 2016 $28,336,000 $6,933,000 +$293,000 +4.4% 01 Jul 2016 30 Sep 2016 10-Q 02 Nov 2017 2017 Q3
Q2 2016 $28,043,000 $8,097,000 +$1,194,000 +17% 01 Apr 2016 30 Jun 2016 10-Q 03 Aug 2017 2017 Q2
Q1 2016 $26,849,000 $6,806,000 +$1,380,000 +25% 01 Jan 2016 31 Mar 2016 10-Q 08 May 2017 2017 Q1
Q4 2015 $25,469,000 $6,500,000 -$2,062,000 -24% 01 Oct 2015 31 Dec 2015 10-K 22 Feb 2018 2017 FY
Q3 2015 $27,531,000 $6,640,000 +$1,104,000 +20% 01 Jul 2015 30 Sep 2015 10-Q 07 Nov 2016 2016 Q3
Q2 2015 $26,427,000 $6,903,000 +$891,000 +15% 01 Apr 2015 30 Jun 2015 10-Q 08 Aug 2016 2016 Q2
Q1 2015 $25,536,000 $5,426,000 -$648,000 -11% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016 2016 Q1
Q4 2014 $26,184,000 $8,562,000 +$4,024,000 +89% 01 Oct 2014 31 Dec 2014 10-K 22 Feb 2017 2016 FY
Q3 2014 $22,160,000 $5,536,000 +$337,000 +6.5% 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2015 2015 Q3
Q2 2014 $21,823,000 $6,012,000 +$1,195,000 +25% 01 Apr 2014 30 Jun 2014 10-Q 07 Aug 2015 2015 Q2
Q1 2014 $20,628,000 $6,074,000 +$799,000 +15% 01 Jan 2014 31 Mar 2014 10-Q 06 May 2015 2015 Q1
Q4 2013 $19,829,000 $4,538,000 -$123,000 -2.6% 01 Oct 2013 31 Dec 2013 10-K 19 Feb 2016 2015 FY
Q3 2013 $19,952,000 $5,199,000 +$64,000 +1.2% 01 Jul 2013 30 Sep 2013 10-Q 05 Nov 2014 2014 Q3
Q2 2013 $19,888,000 $4,817,000 +$761,000 +19% 01 Apr 2013 30 Jun 2013 10-Q 05 Aug 2014 2014 Q2
Q1 2013 $19,127,000 $5,275,000 +$1,554,000 +42% 01 Jan 2013 31 Mar 2013 10-Q 29 Apr 2014 2014 Q1
Q4 2012 $17,573,000 $4,661,000 +$1,440,000 +45% 01 Oct 2012 31 Dec 2012 10-K 18 Feb 2015 2014 FY
Q3 2012 $16,133,000 $5,135,000 +$2,273,000 +79% 01 Jul 2012 30 Sep 2012 10-Q 28 Oct 2013 2013 Q3
Q2 2012 $13,860,000 $4,056,000 +$1,105,000 +37% 01 Apr 2012 30 Jun 2012 10-Q 08 Aug 2013 2013 Q2
Q1 2012 $12,755,000 $3,721,000 +$1,023,000 +38% 01 Jan 2012 31 Mar 2012 10-Q 23 Apr 2013 2013 Q1
Q4 2011 $11,732,000 $3,221,000 01 Oct 2011 31 Dec 2011 10-K 07 Feb 2014 2013 FY
Q3 2011 $2,862,000 01 Jul 2011 30 Sep 2011 10-Q 06 Nov 2012 2012 Q3
Q2 2011 $2,951,000 01 Apr 2011 30 Jun 2011 10-Q 07 Aug 2012 2012 Q2
Q1 2011 $2,698,000 01 Jan 2011 31 Mar 2011 10-Q 10 May 2012 2012 Q1

IRONWOOD PHARMACEUTICALS INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $17,250,000 -$12,600,000 -42% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $29,850,000 -$29,703,000 -50% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 $59,553,000 +$32,505,000 +120% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $27,048,000 +$4,767,000 +21% 01 Jan 2022 31 Dec 2022 10-K 31 Mar 2025 2024 FY
2021 $22,281,000 -$8,894,000 -29% 01 Jan 2021 31 Dec 2021 10-K 16 Feb 2024 2023 FY
2020 $31,175,000 -$103,000 -0.33% 01 Jan 2020 31 Dec 2020 10-K 16 Feb 2023 2022 FY
2019 $31,278,000 -$9,804,000 -24% 01 Jan 2019 31 Dec 2019 10-K 18 Feb 2022 2021 FY
2018 $41,082,000 +$10,177,000 +33% 01 Jan 2018 31 Dec 2018 10-K 17 Feb 2021 2020 FY
2017 $30,905,000 +$1,686,000 +5.8% 01 Jan 2017 31 Dec 2017 10-K 13 Feb 2020 2019 FY
2016 $29,219,000 +$3,750,000 +15% 01 Jan 2016 31 Dec 2016 10-K 25 Feb 2019 2018 FY
2015 $25,469,000 -$715,000 -2.7% 01 Jan 2015 31 Dec 2015 10-K 22 Feb 2018 2017 FY
2014 $26,184,000 +$6,355,000 +32% 01 Jan 2014 31 Dec 2014 10-K 22 Feb 2017 2016 FY
2013 $19,829,000 +$2,256,000 +13% 01 Jan 2013 31 Dec 2013 10-K 19 Feb 2016 2015 FY
2012 $17,573,000 +$5,841,000 +50% 01 Jan 2012 31 Dec 2012 10-K 18 Feb 2015 2014 FY
2011 $11,732,000 +$4,236,000 +57% 01 Jan 2011 31 Dec 2011 10-K 07 Feb 2014 2013 FY
2010 $7,496,000 01 Jan 2010 31 Dec 2010 10-K 21 Feb 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.